Company: HCTI
Filing Date: 2025-05-09
Form Type: S-1/A
Source: 0001213900-25-041190
Chunk: 32

Company: Healthcare Triangle, Inc.
Filing Date: 2025-05-09
Form: S-1/A
Chunk 32
---
 1040 1st Ave, New 
 York, NY 10022.                                                                                                       |

| (18) | Includes 776,516 shares of Common Stock underlying Pre-Funded Warrants;                                    
 11,904,770 shares of Common Stock underlying the Series A Warrants (assuming that all shares are exercised 
 at the floor price of $0.084) and 35,714,310 shares of Common Stock underlying the Series B Warrants       
 (assuming all shares are exercised using zero exercise price option and prior to such exercise the         
 exercise price of the Series B Warrants are reset the floor price of $0.084)                               |

| (19) | The principal address of Alta Partners, LLC is 1205 Franklin Ave, Ste 320, Garden City, NY 11530. |

| (20) | Includes 776,516 shares of Common Stock underlying Pre-Funded Warrants;                                    
 11,904,770 shares of Common Stock underlying the Series A Warrants (assuming that all shares are exercised 
 at the floor price of $0.084) and 35,714,310 shares of Common Stock underlying the Series B Warrants       
 (assuming all shares are exercised using zero exercise price option and prior to such exercise the         
 exercise price of the Series B Warrants are reset the floor price of $0.084)                               |

| (21) | Ascent is a subsidiary of Dominion Capital, LLC, another accredited and institutional investor in the                                
 Company and the table set forth above excludes all of the Company’s securities held by Dominion Capital, LLC. The address for Ascent 
 is 19505 Biscayne Blvd., Suite 2350, Aventura, FL 33180.                                                                             |

| (22) | Includes 776,516 shares of Common Stock underlying Pre-Funded Warrants;                                    
 11,904,770 shares of Common Stock underlying the Series A Warrants (assuming that all shares are exercised 
 at the floor price of $0.084) and 35,714,310 shares of Common Stock underlying the Series B Warrants       
 (assuming all shares are exercised using zero exercise price option and prior to such exercise the         
 exercise price of the Series B Warrants are reset the floor price of $0.084)                               |

| (23) | David Feldman and Joel Arber are the Directors of L1 Capital Global Opportunities Master Fund, Ltd. As                                    
 such, L1 Capital Global Opportunities Master Fund, Ltd., Mr. Feldman